Effect of voltage-gated and capacitative calcium entry blockade on agonist-induced constriction of equine laminar blood vessels

American Journal of Veterinary Research

Volumn 68, Issue 7, 2007, Pages 722-729

  Peroni, John F ^a   Moore, James N ^a   Noschka, Erik ^a   Lewis, Tristan H ^a   Lewis, Stephen J ^a   Roberston, Tom P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; DILTIAZEM; ENDOTHELIN 1; PHENYLEPHRINE; PROSTAGLANDIN F2 ALPHA; SEROTONIN; TRIFLUOROMETHYLPHENYLIMIDAZOLE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; HORSE; LAMINAR ARTERY; LAMINAR VEIN; MUSCLE ISOMETRIC CONTRACTION; MYOGRAPHY; NONHUMAN; SKIN BLOOD VESSEL; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DINOPROST; ENDOTHELIN-1; HOOF AND CLAW; HORSES; IMIDAZOLES; LOGISTIC MODELS; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; SEROTONIN; VASOCONSTRICTION;

ANIMALIA; EQUIDAE;

EID: 34547533526     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.7.722     Document Type: Article

References (28)

1. Brumbaugh GW, Sumano Lopez H, Hoyas Sepulveda ML. The pharmacologic basis for the treatment of developmental and acute laminitis. Vet Clin North Am Equine Pract 1999;15:345-362.
2. Hood DM. The pathophysiology of developmental and acute laminitis. Vet Clin North Am Equine Pract 1999;15:321-343.
3. Adair HS III, Goble DO, Schmidhammer JL, et al. Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses. Am J Vet Res 2000;61:862-868.
4. Galey FD, Twardock AR, Goetz TE, et al. Gamma scintigraphic analysis of the distribution of perfusion of blood in the equine foot during black walnut (Juglans nigra)-induced laminitis. Am J Vet Res 1990;51:688-695.
5. Hood DM, Amoss MS, Grosenbaugh DA. Equine laminitis: a potential model of Raynaud's phenomenon. Angiology 1990;41:270-277.
6. Hood DM, Grosenbaugh DA, Mostafa MB, et al. The role of vascular mechanisms in the development of acute equine laminitis. J Vet Intern Med 1993;7:228-234.
7. Robinson NE, Scott JB, Dabney JM, et al. Digital vascular responses and permeability in equine alimentary laminitis. Am J Vet Res 1976;37:1171-1176.
8. Allen D Jr, Clark ES, Moore JN, et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 1990;51:1930-1934.
9. Eaton SA, Allen D, Eades SC, et al. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Am J Vet Res 1995;56:1338-1344.
10. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 1998;508:199-209.
11. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res 2006;98:868-878.
12. Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev 1997;77:901-930.
13. Snetkov VA, Knock GA, Aaronson PI, et al. Capacitative calcium entry as a pulmonary specific vasoconstrictor mechanism in small muscular arteries of the rat. Br J Pharmacol 2003;140:97-106.
14. Robertson TP, Peroni JF, Lewis SJ, et al. Effects of induction of capacitative calcium entry on equine laminar microvessels. Am J Vet Res 2005;66:1877-1880.
15. AVMA Panel on Euthansia. 2001 Report of the AVMA Panel on Euthanasia (Erratum published in J Am Vet Med Assoc 2001;218:1884). J Am Vet Med Assoc 2001;218:669-696.
16. Peroni JF, Harrison WE, Moore JN, et al. Black walnut extract-induced laminitis in horses is associated with heterogeneous dysfunction of the laminar microvasculature. Equine Vet J 2005;37:546-551.
17. Peroni JF, Moore JN, Noschka E, et al. Predisposition for venoconstriction in the equine laminar dermis: implications in equine laminitis. J Appl Physiol 2006;100:759-763.
18. Winer BJ. Analysis of variance. In: Statistics principles in experimental design. New York: McGraw-Hill Book Co, 1971;752-809.
19. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
20. Baxter GM, Laskey RE, Tackett RL, et al. In vitro reactivity of digital arteries and veins to vasoconstrictive mediators in healthy horses and in horses with early laminitis. Am J Vet Res 1989;50:508-517.
21. Elliott J. Alpha-adrenoceptors in equine digital veins: evidence for the presence of both alpha1 and alpha2-receptors mediating vasoconstriction. J Vet Pharmacol Ther 1997;20:308-317.
22. Ramaswamy CM, Eades SC, Venugopal CS, et al. Plasma concentrations of endothelin-like immunoreactivity in healthy horses and horses with naturally acquired gastrointestinal tract disorders. Am J Vet Res 2002;63:454-458.
23. Bailey SR, Elliott J. Plasma 5-hydroxytryptamine constricts equine digital blood vessels in vitro: implications for pathogenesis of acute laminitis. Equine Vet J 1998;30:124-130.
24. Waguespack RW, Cochran A, Belknap JK. Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses. Am J Vet Res 2004;65:1724-1729.
25. Katwa LC, Johnson PJ, Ganjam VK, et al. Expression of endothelin in equine laminitis. Equine Vet J 1999;31:243-247.
26. Eades SC, Stokes AM, Moore RM. Effects of an endothelin receptor antagonist and nitroglycerin on digital vascular function in horses during the prodromal stages of carbohydrate overload-induced laminitis. Am J Vet Res 2006;67:1204-1211.
27. Sonkusare S, Palade PT, Marsh JD, et al. Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vascul Pharmacol 2006;44:131-142.
28. Gibson A, Fernandes F, Wallace P, et al. Selective inhibition of thapsigargin-induced contraction and capacitative calcium entry in mouse anococcygeus by trifluoromethylphenylimidazole (TRIM). Br J Pharmacol 2001;134:233-236.